Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Melanoma Skin”

3,267 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,267 results

Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Testing effectiveness (Phase 2)WithdrawnNCT01933061
What this trial is testing

Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Celgene Corporation
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Not applicableStudy completedNCT02050594
What this trial is testing

Ipilimumab 12-month Intensive Pharmacovigilance Protocol

Who this might be right for
Melanoma
Bristol-Myers Squibb 6
Early research (Phase 1)Study completedNCT00687622
What this trial is testing

Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma

Who this might be right for
Solid Tumours
GlaxoSmithKline 206
Testing effectiveness (Phase 2)Study completedNCT00139360
What this trial is testing

Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Haukeland University Hospital 35
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Early research (Phase 1)Ended earlyNCT01032122
What this trial is testing

Rituximab in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Medical University of Vienna 9
Very early researchLooking for participantsNCT04741997
What this trial is testing

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVBRAF V600 Mutation
H. Lee Moffitt Cancer Center and Research Institute 50
Early research (Phase 1)Study completedNCT00101270
What this trial is testing

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more
National Cancer Institute (NCI) 24
Very early researchEnded earlyNCT03060356
What this trial is testing

Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)

Who this might be right for
Malignant MelanomaBreast Cancer
University of Pennsylvania 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT06190951
What this trial is testing

A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 151
Early research (Phase 1)Study completedNCT00496860
What this trial is testing

Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies

Who this might be right for
Progressive Metastatic Malignancies
Altor BioScience 26
Large-scale testing (Phase 3)Study completedNCT01359956
What this trial is testing

Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma

Who this might be right for
Malignant MelanomaRecurrent Melanoma
National Cancer Institute, Naples 269
Not applicableStudy completedNCT02310451
What this trial is testing

Study of Molecular Mechanisms Implicated in the Pathogenesis of Melanoma. Role of Exosomes

Who this might be right for
Metastatic Melanoma
Centre Hospitalier Universitaire de Nice 15
Not applicableUnknownNCT00390351
What this trial is testing

Investigate the Diagnostic Value and Possibilities of OCT in Non-Melanoma Skin Cancer.

Who this might be right for
Skin Neoplasms
Zealand University Hospital 120
Not applicableStudy completedNCT02902822
What this trial is testing

Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo

Who this might be right for
ErysipelasImpetigoHerpes Zoster+7 more
Centro Studi Gised 461
Testing effectiveness (Phase 2)UnknownNCT05767879
What this trial is testing

(Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma

Who this might be right for
Melanoma Stage IIIIn-Transit Metastasis of Cutaneous Melanoma
Leiden University Medical Center 28
Not applicableLooking for participantsNCT06254196
What this trial is testing

Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies

Who this might be right for
Lung NeoplasmMelanoma
Regina Elena Cancer Institute 40
Not applicableActive Not RecruitingNCT01942603
What this trial is testing

Minimal SN Tumor Burden

Who this might be right for
Cutaneous Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 296
Load More Results